Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-40,000
Closed -$416K 144
2020
Q1
$416K Sell
40,000
-45,000
-53% -$573K 0.08% 127
2019
Q4
$1.52M Buy
85,000
+10,000
+13% +$148K 0.19% 98
2019
Q3
$936K Buy
75,000
+20,000
+36% +$329K 0.14% 123
2019
Q2
$1.09M Buy
55,000
+10,000
+22% +$214K 0.16% 118
2019
Q1
$948K Buy
+45,000
New +$822K 0.13% 121

Other funds holding AXGN

Formula Growth's AXGN Position: Q2 2020 in Review

Formula Growth sold out of Axogen (AXGN) in Q2 2020, closing a stake of 40,000 shares — an estimated $416K sold.

Formula Growth first reported a position in AXGN in Q1 2019 and held it in 5 quarters. The position peaked at $1.52M in Q4 2019. 114 funds tracked by Wall St. Rank hold AXGN as of Q2 2020.

  • Formula Growth reported no remaining Axogen position as of Q2 2020 after selling out during the quarter.
  • Formula Growth sold 40,000 Axogen shares in Q2 2020, an estimated $416K.
  • Formula Growth first reported a position in Axogen in Q1 2019 and held it in 5 quarters.
  • Formula Growth's Axogen position peaked at $1.52M in Q4 2019.
  • 114 funds tracked by Wall St. Rank held Axogen as of Q2 2020.

Based on Formula Growth's 13F filing for Q2 2020, filed 13 Aug 2020.